Group One Trading
GPCR icon

Group One Trading’s Structure Therapeutics GPCR Stock Holding History

Group One Trading’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-986
Closed -$40.3K – 8513
2025
Q3 		$27.6K Sell
986
-7,079
-88% -$141K ﹤0.01% 6436
2025
Q2 		$167K Sell
8,065
-40,852
-84% -$898K ﹤0.01% 4513
2025
Q1 		$847K Buy
48,917
+27,350
+127% +$670K ﹤0.01% 2606
2024
Q4 		$585K Buy
21,567
+15,758
+271% +$559K ﹤0.01% 3044
2024
Q3 		$255K Sell
5,809
-6,565
-53% -$254K ﹤0.01% 3406
2024
Q2 		$486K Buy
+12,374
New +$508K ﹤0.01% 2591
2024
Q1 		– Sell
-17,914
Closed -$755K – 7388
2023
Q4 		$730K Buy
+17,914
New +$1.03M ﹤0.01% 2750

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Group One Trading's GPCR Position: Q4 2025 in Review

Group One Trading sold out of Structure Therapeutics (GPCR) in Q4 2025, closing a stake of 986 shares — an estimated $40.3K sold.

Group One Trading first reported a position in GPCR in Q4 2023 and held it in 7 quarters. The position peaked at $847K in Q1 2025. 197 funds tracked by Wall St. Rank hold GPCR as of Q4 2025.

  • Group One Trading reported no remaining Structure Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 986 Structure Therapeutics shares in Q4 2025, an estimated $40.3K.
  • Group One Trading first reported a position in Structure Therapeutics in Q4 2023 and held it in 7 quarters.
  • Group One Trading's Structure Therapeutics position peaked at $847K in Q1 2025.
  • 197 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.